4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001549
CHIEF COMMERCIAL OFFICER sold 10,507 shares at $37.01 ($388,841)
- CHIEF COMMERCIAL OFFICER acquired 10,507 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-15 | Option exercise 10b5-1 | +10,507 | $33.44 | $351,354 | 10,507 | D: show line 1 in the form |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-15 | Sale 10b5-1 | −10,507 | $37.01 | $388,841 | 0 | D: show line 2 in the form |
| Open-market sales · 10,507 sh · avg $37.01 · $388,841 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-15 | Option exercise · Stock Option 10b5-1 | −10,507 | 36,213 | D: show line 3 in the form |
Loading xslF345X05/form4-01162025_040101.xml…